IDEAS home Printed from https://ideas.repec.org/p/osf/socarx/z5mf6_v2.html
   My bibliography  Save this paper

Power, Disputes, and Geopolitics in the Pharmaceutical Sector

Author

Listed:
  • Stacciarini, João Henrique Santana

    (Federal University of Goiás)

Abstract

The pharmaceutical sector achieved global revenues of USD 1.6 trillion in 2023, underscoring its immense economic power and strategic influence on the modern economy and global politics. This article, grounded in extensive data collection, systematization, and analysis, explores the dynamics of this power and influence. It examines the economic and political value of companies in the sector, the conflicts between corporations and nations, the geopolitical role of the sector during the COVID-19 pandemic, and its capacity to shape domestic policies through intensive lobbying, financial contributions to lawmakers, and interactions with regulatory and oversight bodies.

Suggested Citation

  • Stacciarini, João Henrique Santana, 2024. "Power, Disputes, and Geopolitics in the Pharmaceutical Sector," SocArXiv z5mf6_v2, Center for Open Science.
    • Handle: RePEc:osf:socarx:z5mf6_v2
    DOI: 10.31219/osf.io/z5mf6_v2
    as

    Download full text from publisher

    File URL: https://osf.io/download/67a0f17503274f895c769a3f/
    Download Restriction: no
    File URL: https://libkey.io/10.31219/osf.io/z5mf6_v2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. DiMasi, Joseph A. & Grabowski, Henry G. & Hansen, Ronald W., 2016. "Innovation in the pharmaceutical industry: New estimates of R&D costs," Journal of Health Economics, Elsevier, vol. 47(C), pages 20-33.
    2. Priya Gauttam & Bawa Singh & Jaspal Kaur, 2020. "COVID-19 and Chinese Global Health Diplomacy: Geopolitical Opportunity for China’s Hegemony?," Millennial Asia, , vol. 11(3), pages 318-340, December.
    3. Darius N. Lakdawalla, 2018. "Economics of the Pharmaceutical Industry," Journal of Economic Literature, American Economic Association, vol. 56(2), pages 397-449, June.
    4. Salamon, Lester M. & Siegfried, John J., 1977. "Economic Power and Political Influence: The Impact of Industry Structure on Public Policy," American Political Science Review, Cambridge University Press, vol. 71(3), pages 1026-1043, September.
    5. Fazal, Tanisha M., 2020. "Health Diplomacy in Pandemical Times," International Organization, Cambridge University Press, vol. 74(S1), pages 78-97, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Stacciarini, João Henrique Santana, 2024. "Power, Disputes, and Geopolitics in the Pharmaceutical Sector," SocArXiv z5mf6_v1, Center for Open Science.
    2. Stacciarini, João Henrique Santana, 2024. "Power, Disputes, and Geopolitics in the Pharmaceutical Sector," SocArXiv z5mf6, Center for Open Science.
    3. Stacciarini, João Henrique Santana, 2025. "Poder, Disputas y Geopolítica en el Sector Farmacéutico," SocArXiv ky4z7, Center for Open Science.
    4. Stacciarini, João Henrique Santana, 2023. "The Consolidation of the Pharmaceutical Sector in the Global Economy: Growth, Influence, Deviations, and Marketing," SocArXiv 6728p_v1, Center for Open Science.
    5. Fabian Gaessler & Stefan Wagner, 2022. "Patents, Data Exclusivity, and the Development of New Drugs," The Review of Economics and Statistics, MIT Press, vol. 104(3), pages 571-586, May.
    6. Pierre Dubois & Ashvin Gandhi & Shoshana Vasserman, 2022. "Bargaining and International Reference Pricing in the Pharmaceutical Industry," NBER Working Papers 30053, National Bureau of Economic Research, Inc.
    7. Tobias Basse & Christoph Schwarzbach & J.-Matthias Schulenburg, 2023. "Dividend policy issues in the European pharmaceutical industry: new empirical evidence," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(5), pages 803-816, July.
    8. Enes Işık & Özgür Orhangazi, 2022. "Profitability and drug discovery," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 31(4), pages 891-904.
    9. Sandeep Singh & Jagmeet Bawa & Bawa Singh & Balinder Singh & Shankar Lal Bika, 2024. "Analyzing GAVI the Vaccine Alliance as a Global Health Partnership Model: A Constructivist Analysis of the Global Health Crisis," Millennial Asia, , vol. 15(3), pages 447-464, September.
    10. Ute Laermann-Nguyen & Martin Backfisch, 2021. "Innovation crisis in the pharmaceutical industry? A survey," SN Business & Economics, Springer, vol. 1(12), pages 1-37, December.
    11. Venkatanarayana Motkuri & Rudra Narayan Mishra, 2020. "Pharmaceutical Market and Drug Price Policy in India," Review of Development and Change, , vol. 25(1), pages 30-53, June.
    12. Vijay Kumar Chattu & Vishal B. Dave & K. Srikanth Reddy & Bawa Singh & Biniyam Sahiledengle & Demisu Zenbaba Heyi & Cornelius Nattey & Daniel Atlaw & Kioko Jackson & Ziad El-Khatib & Akram Ali Eltom, 2021. "Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review," IJERPH, MDPI, vol. 18(22), pages 1-22, November.
    13. Francis,David C. & Kubinec ,Robert, 2022. "Beyond Political Connections : A Measurement Model Approach to Estimating Firm-levelPolitical Influence in 41 Economies," Policy Research Working Paper Series 10119, The World Bank.
    14. Dosis, Anastasios & Muthoo, Abhinay, 2019. "Experimentation in Dynamic R&D Competition," CRETA Online Discussion Paper Series 52, Centre for Research in Economic Theory and its Applications CRETA.
    15. Branstetter, Lee & Chatterjee, Chirantan & Higgins, Matthew J., 2022. "Generic competition and the incentives for early-stage pharmaceutical innovation," Research Policy, Elsevier, vol. 51(10).
    16. Behnam Karamshahi & Zeinab Azami & Tabandeh Salehi, 2018. "The association between competition power in markets and tax avoidance: evidence from Tehran stock exchange," Eurasian Business Review, Springer;Eurasia Business and Economics Society, vol. 8(3), pages 323-339, September.
    17. Mauro Caselli & Arpita Chatterjee & Shengyu Li, 2023. "Productivity and Quality of Multi-product Firms," Discussion Papers 2023-10, School of Economics, The University of New South Wales.
    18. Abe C. Dunn & Lasanthi Fernando & Eli Liebman, 2024. "How Much Are Medical Innovations Worth? A Detailed Analysis Using Cost-Effectiveness Studies," BEA Papers 0132, Bureau of Economic Analysis.
    19. Alfred B. Ordman, 2022. "When Will the FDA Do What Is in People’s Best Interests?," American Journal of Economics and Sociology, Wiley Blackwell, vol. 81(4), pages 721-751, September.
    20. Edouard Debonneuil & Anne Eyraud-Loisel & Frédéric Planchet, 2018. "Can Pension Funds Partially Manage Longevity Risk by Investing in a Longevity Megafund?," Risks, MDPI, vol. 6(3), pages 1-27, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:osf:socarx:z5mf6_v2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: OSF (email available below). General contact details of provider: https://arabixiv.org .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.